What is RMD's current stock price?

As of now, RMD is trading at $271.63, with a daily change of +1.72%.

What are the risks associated with RMD stock?

RMD has Low, risk level based on volatility, sector strength, volume, investor confidence and outlook.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

RMD Stock Analysis & IQ Rating | ResMed

RMD

ResMed

$271.63

+$4.58 | +1.72%

Set Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$293.81

MKT CAP

$39.57B

52W Low

$199.92

VOL

$1.50M

P/E Ratio

26.85

AVG VOL

$991.37K

RSI

66.63

TREND

Uptrend

RMD Stock IQ

Login to see ResMed (RMD) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

RMD Target Price

Login to display

Not Enough Information

Strengths

RMD Rewards

Earnings are forecast to grow

RMD Rewards

Outperform the market

RMD Price Performance

$257.84 (+5.35%)

$252.6 (+7.53%)

$271.71 (-0.03%)

$229.65 (+18.28%)

1year

6month

3month

1month

RMD Analysts Opinion

Overall standing based on market and analyst consensus. menu Hover over the category for more information

RMD Analysts Opinion

RMD Analysts opinion is negative and it remained unchanged from the past 3 months

RMD Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

95%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

RMD Street Sentiment

RMD Street Sentiment is extremely bullish and have positive views on the near-term outlook

RMD Risk Level

RMD has Low risk level

Low

LOW

HIGH

RMD Performance Sentiment

Sentiments overview associated with events and the stock performance

95%

5%

Positive

Negative

19 out of 20
events present

1 out of 20
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Key Price Levels

Average key support and resistance price levels

Support
Price

$267.05

Resistance
Price

$251.57

Current Price Range

N/A

Show methods +

Analyst Consensus

Recent Upgrades and Downgrades

100%

Buy

Hold

Sell

Consensus Rating

STRONG BUY

4

0

Date

Action

Rating

Firm

Nov 04, 2025

Reiterate

Outperform

Baird

Nov 01, 2025

Reiterate

Outperform

Mizuho

Nov 01, 2025

Reiterate

Overweight

KeyBanc

Oct 21, 2025

Reiterate

Overweight

Morgan Stanley

RMD Latest Analysis +

RMD Makes ish Cross Above Critical Moving Average. In trading on Wednesday shares of ResMed Inc. (Symbol: RMD) crossed above their 200 day moving average of $258.34 changing hands as high as $264.88 per share. ResMed Inc. shares are currently trading up about 5% on the day. The chart below shows the one year performance of R

Wed Feb 4, 2026

$263.03 | +4.62%

Momentum

Technical

Analysts Maintain Case On ResMed Despite Competition Concerns. On Thursday RMD) reported that second-quarter fiscal 2026 adjusted earnings of 2.81 beating the .Quarterly sales increased 11% year over year to $1.42 billion surpassing the consensus estimate of $1.396 billion.Sales increased 9% on a constant currency basis driven by increased demand for our portfolio of and accessories.Residential Care Software revenue increased by 5% on a constant currency basis.In December 2025 the United State

Fri Jan 30, 2026

$258.31 | +0.27%

Activity

ResMed declares $0.60 dividend.

Fri Jan 30, 2026

$258.31 | +0.27%

Activity

ResMed (RMD) Q2 Earnings and Revenues Beat Estimates. ResMed (RMD) delivered earnings and revenue surprises of 4.59% and 2.30% respectively for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Thu Jan 29, 2026

$257.61 | -0.04%

Earnings

Heres Why ResMed (RMD) is a Strong Momentum Stock. The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why you should take advantage.

Thu Jan 29, 2026

$257.61 | -0.04%

Momentum

Will ResMed (RMD) Beat Estimates Again in Its Next Earnings Report?. ResMed (RMD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Wed Jan 28, 2026

$257.72 | +0.87%

Earnings

Potential

Stay Ahead of the Game With ResMed (RMD) Q2 Earnings: Wall Streets Insights on Key Metrics. Besides Wall Streets top-and-bottom-line estimates for ResMed (RMD) review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2025.

Tue Jan 27, 2026

$255.50 | +0.02%

Earnings

Why ResMed (RMD) is a Top Growth Stock for the Long-Term. Wondering how to pick strong market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Mon Jan 26, 2026

$255.47 | +1.22%

Potential

Runners Also Watch

Close Price

Change

IRTC

iRhythm Technologies

146.47

-0.19%

BSX

Boston Scientific

76.27

-1.76%

BDX

Becton, Dickinson and

210.02

+1.70%

FAQ About RMD Stock Insights

What is RMD current stock price?

What are RMD stock strengths?

What is RMD Risk Level?

What is RMD market cap and volume?

What is RMD current Stock IQ?

Should I buy RMD stock right now?

Is RMD a Strong Buy right now?

What does a 'Strong Buy' rating mean for RMD?

What does a 'Strong Sell' rating mean for RMD?

What factors influence RMD's Stock IQ?

Explore our RMD Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored RMD Stock Strategies
Effective Risk Management

FIND US ON

Receive our RMD Daily Alerts

Join over 5,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

RMD

ResMed

Set Alerts

Current Price

$271.63

+$4.58 | +1.72%

52W High

$293.81

MKT CAP

$39.57B

52W Low

$199.92

VOL

$1.50M

P/E Ratio

26.85

AVG VOL

$991.37K

RSI

66.63

TREND

Uptrend

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Runners Also Watch

Symbol

Close

Change

IRTC

iRhythm Technologies

146.47

-0.19%

BSX

Boston Scientific

76.27

-1.76%

BDX

Becton, Dickinson and

210.02

+1.70%

RMD Price Performance

$257.84 (+5.35%)

$252.6 (+7.53%)

$271.71 (-0.03%)

$229.65 (+18.28%)

1year

6month

3month

1month

RMD Analysts Opinion

Overall standing per market and analyst expectations. menu Hover over the category for more information

RMD Analysts Opinion

RMD Analysts opinion is negative and it remained unchanged from the past 3 months

RMD Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

95%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

RMD Street Sentiment

RMD Street Sentiment is extremely bullish and have positive views on the near-term outlook

RMD Risk Level

RMD has Low risk level

Low

LOW

HIGH

RMD Performance Sentiment

Sentiments overview associated with events and the stock performance.

95%

5%

Positive

Negative

19 out of 20
events present

1 out of 20
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Key Price Levels

Average key support and resistance price levels

Support
Price

$267.05

Resistance
Price

$251.57

Current Price Range

N/A

Show methods +

Latest Analyst Actions

Overall Wall Street Rating

100%

Buy

Hold

Sell

Consensus Rating

STRONG BUY

4

0

Date

Action

Rating

Firm

Nov 04, 2025

Reiterate

Outperform

Baird

Nov 01, 2025

Reiterate

Outperform

Mizuho

Nov 01, 2025

Reiterate

Overweight

KeyBanc

Oct 21, 2025

Reiterate

Overweight

Morgan Stanley

RMD Stock IQ

Login to unlock ResMed (RMD) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Target Price

Login to display

Stock Insights

Strengths

RMD Rewards

Earnings are forecast to grow

RMD Rewards

Outperform the market

RMD Latest Analysis

RMD Makes ish Cross Above Critical Moving Average. In trading on Wednesday shares of ResMed Inc. (Symbol: RMD) crossed above their 200 day moving average of $258.34 changing hands as high as $264.88 per share. ResMed Inc. shares are currently trading up about 5% on the day. The chart below shows the one year performance of R

Wed Feb 4, 2026

$263.03 | +4.62%

Momentum

Technical

Analysts Maintain Case On ResMed Despite Competition Concerns. On Thursday RMD) reported that second-quarter fiscal 2026 adjusted earnings of 2.81 beating the .Quarterly sales increased 11% year over year to $1.42 billion surpassing the consensus estimate of $1.396 billion.Sales increased 9% on a constant currency basis driven by increased demand for our portfolio of and accessories.Residential Care Software revenue increased by 5% on a constant currency basis.In December 2025 the United State

Fri Jan 30, 2026

$258.31 | +0.27%

Activity

ResMed declares $0.60 dividend.

Fri Jan 30, 2026

$258.31 | +0.27%

Activity

ResMed (RMD) Q2 Earnings and Revenues Beat Estimates. ResMed (RMD) delivered earnings and revenue surprises of 4.59% and 2.30% respectively for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Thu Jan 29, 2026

$257.61 | -0.04%

Earnings

Heres Why ResMed (RMD) is a Strong Momentum Stock. The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why you should take advantage.

Thu Jan 29, 2026

$257.61 | -0.04%

Momentum

Will ResMed (RMD) Beat Estimates Again in Its Next Earnings Report?. ResMed (RMD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Wed Jan 28, 2026

$257.72 | +0.87%

Earnings

Potential

Stay Ahead of the Game With ResMed (RMD) Q2 Earnings: Wall Streets Insights on Key Metrics. Besides Wall Streets top-and-bottom-line estimates for ResMed (RMD) review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2025.

Tue Jan 27, 2026

$255.50 | +0.02%

Earnings

Discover RMD Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of RMD. We're here to help you make informed investment decisions today.

FIND US ON

Receive our RMD Daily Alerts

Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

RMD Stock trends

RMD Stock performance

RMD Stock analysis

RMD investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing RMD

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing RMD

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

RMD Stock Analysis & IQ Rating | ResMed

RMD Stock IQ

RMD Target Price

RMD Analysts Opinion

RMD Street Sentiment

RMD Risk Level

RMD Performance Sentiment

Key Price Levels

Analyst Consensus

Explore our RMD Stock insights

Receive our RMD Daily Alerts

RMD Street Sentiment

RMD Risk Level

Key Price Levels

Latest Analyst Actions

Discover RMD Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of RMD. We're here to help you make informed investment decisions today.

Receive our RMD Daily Alerts

RMD Alerts